Protinash Therapeutics Private Limited

Founded in 2019 and headquartered in Telangana, India.

2019 | Hyderabad, Telangana (India) | Inactive
Last Updated: December 31, 2024

Protinash Therapeutics Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth -119.31%
  • Ebitda -119.31%
  • Net Worth -244.39%
  • Total Assets 43.77%

About Protinash Therapeutics

Protinash Therapeutics Private Limited (PTPL) is Strike Off company established on 16 Aug 2019 with its office registered at Hyderabad, Telangana, India and has been running since 5 Year, 5 Months with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 31 Dec 2024.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U73100TG2019PTC134829

  • Company No.

    134829

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 Aug 2019

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Research & Development

Who are the key members and board of directors at Protinash Therapeutics?

Board Members (2)

Name Designation Appointment Date Status
Hemant Joshi Country flag representing In Director 16-Aug-2019 Current
Hormuzd Mulla Country flag representing In Director 16-Aug-2019 Current

Financial Performance of Protinash Therapeutics.

Protinash Therapeutics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 119.31% decrease in profit. The company's net worth observed a substantial decline by a decrease of 244.39%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
43.77%
Profit or Loss
-119.31%
Net Worth
-244.39%
EBITDA
-119.31%

What is the Ownership and Shareholding Structure of Protinash Therapeutics?

Unlock access to Protinash Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Protinash Therapeutics?

Unlock and access historical data on people associated with Protinash Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Protinash Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Protinash Therapeutics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Protinash Therapeutics

Recent activity within the organization

  • Annual General Meeting

    Protinash Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Protinash Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

    31 Mar 2023

  • Director Appointment

    Hemant Vasant Joshi was appointed as a Director was appointed as a Director on 16 Aug 2019 & has been associated with this company since 5 years 5 months .

    16 Aug 2019

  • Director Appointment

    Hormuzd Rayomand Mulla was appointed as a Director was appointed as a Director on 16 Aug 2019 & has been associated with this company since 5 years 5 months .

    16 Aug 2019

  • Company Incorporation

    Protinash Therapeutics Private Limited was registered on 16 Aug 2019 with Roc Hyderabad & aged 5 years 5 months as per MCA records.

    16 Aug 2019

Frequently asked questions

  • Protinash Therapeutics Private Limited was incorporated on 16 Aug 2019.

  • The authorized share capital of Protinash Therapeutics Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Protinash Therapeutics Private Limited.

    • Hemant Vasant Joshi
    • Hormuzd Rayomand Mulla
  • As per Ministry of Corporate Affairs (Mca), the registered address of Protinash Therapeutics Private Limited is B 807 Necklace Pride Kavadiguda Main Road India, Secunderabad, Telangana, 500003.

  • The corporate identification number (CIN) of Protinash Therapeutics Private Limited is U73100TG2019PTC134829 and the company number is 134829 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2022 indicates that The net worth of Protinash Therapeutics Private Limited has experienced an downturn of -244.39%.

  • The most recent Balance Sheet for Protinash Therapeutics Private Limited was filed with the ROC on 31 Mar 2023.